Rare diseases
Investigational molecules
Locations
Back to Italy126 clinical trials in Catanzaro, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
ItalyStudy on the Effects of Siplizumab in Adults with New Onset Type 1 Diabetes
ItalyStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
ItalyStudy of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients
ItalyStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
ItalyStudy on the Effectiveness and Safety of Lenvatinib, Pembrolizumab, and Chemotherapy for Patients with Advanced or Metastatic Gastroesophageal Cancer
ItalyStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
ItalyStudy on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19
ItalyStudy on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment
ItalyStudy to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
ItalyStudy on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
ItalyStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on innovative treatments for various cancers, including colorectal cancer, ovarian cancer, and breast cancer. Studies evaluate targeted therapies and maintenance treatments to improve patient outcomes.
Particular emphasis on biomarker-driven treatment approaches and personalized medicine strategies.
Studies examining new therapeutic options for inflammatory bowel diseases, with trials targeting Crohn's Disease and Ulcerative Colitis. Research focuses on novel biological treatments and long-term disease management.
Emphasis on developing treatments for patients with inadequate response to conventional therapies.
Research initiatives addressing Type 2 Diabetes, obesity, and related metabolic conditions. Studies evaluate new medications for weight management and cardiovascular outcomes in diabetic patients.
Focus on innovative therapeutic approaches and long-term disease control strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
